3,298 reports of this reaction
0.8% of all ADAPALENE reports
#19 most reported adverse reaction
URTICARIA is the #19 most commonly reported adverse reaction for ADAPALENE, manufactured by Alchemee, LLC. There are 3,298 FDA adverse event reports linking ADAPALENE to URTICARIA. This represents approximately 0.8% of all 416,192 adverse event reports for this drug.
Patients taking ADAPALENE who experience urticaria should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
URTICARIA is a less commonly reported adverse event for ADAPALENE, but still significant enough to appear in the safety profile.
In addition to urticaria, the following adverse reactions have been reported for ADAPALENE:
The following drugs have also been linked to urticaria in FDA adverse event reports:
URTICARIA has been reported as an adverse event in 3,298 FDA reports for ADAPALENE. This does not prove causation, but indicates an association observed in post-market surveillance data.
URTICARIA accounts for approximately 0.8% of all adverse event reports for ADAPALENE, making it a notable side effect.
If you experience urticaria while taking ADAPALENE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.